Ignite Creation Date:
2025-12-24 @ 9:10 PM
Ignite Modification Date:
2025-12-29 @ 12:32 PM
Study NCT ID:
NCT01519804
Status:
COMPLETED
Last Update Posted:
2016-09-02
First Post:
2011-12-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Onartuzumab (MetMAb) Versus Placebo in Combination With Paclitaxel Plus Platinum in Patients With Squamous Non-Small Cell Lung Cancer
Sponsor:
Genentech, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-04
Start Date Type:
None
Primary Completion Date:
2014-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-09
Completion Date Type:
ACTUAL
First Submit Date:
2011-12-19
First Submit QC Date:
None
Study First Post Date:
2012-01-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-07-01
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2016-09-01
Last Update Post Date:
2016-09-02
Last Update Post Date Type:
ESTIMATED